Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
Open Access
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Annals of Intensive Care
- Vol. 6 (1) , 77-9
Abstract
No abstract availableKeywords
Funding Information
- ESTOR, TORAY (unrestricted research grant)
This publication has 30 references indexed in Scilit:
- A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe InvestigatorsIntensive Care Medicine, 2015
- Polymyxin B Hemoperfusion in Clinical Practice: The Picture from an Unbound Collaborative RegistryBlood Purification, 2014
- The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS studyCritical Care, 2013
- Early Use of Polymyxin B Hemoperfusion in Abdominal Septic ShockJAMA, 2009
- The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*Critical Care Medicine, 2009
- Polymyxin-B hemoperfusion inactivates circulating proapoptotic factorsIntensive Care Medicine, 2008
- Effects of PMX‐DHP Treatment for Patients With Directly Induced Acute Respiratory Distress SyndromeTherapeutic Apheresis and Dialysis, 2007
- Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)Therapeutic Apheresis and Dialysis, 2003
- Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shockAmerican Journal of Kidney Diseases, 2002
- The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre studyIntensive Care Medicine, 1999